BriaCell Therapeutics Corp. (BCTX) DCF Valuation

BriaCell Therapeutics Corp. (BCTX) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

BriaCell Therapeutics Corp. (BCTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your BriaCell Therapeutics Corp. (BCTX) valuation analysis using our cutting-edge DCF Calculator! This Excel template comes preloaded with real (BCTX) data, giving you the flexibility to adjust forecasts and assumptions to accurately determine the intrinsic value of BriaCell Therapeutics Corp.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -2.8 -6.0 -10.5 -21.3 -3.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -2.8 -6.0 -10.5 -21.3 -3.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 39.7 28.5 14.7 .6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .5 1.0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .1 .3 .8 5.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.8 4.7 -10.5 -21.3 -3.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.7 4.9 -10.3 -21.3 .1 -4.0 .0 .0 .0 .0
WACC, % 13.02 13.02 13.02 13.02 13.02 13.02 13.02 13.02 13.02 13.02
PV UFCF
SUM PV UFCF -3.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -1
Equity Value -3
Diluted Shares Outstanding, MM 16
Equity Value Per Share -0.18

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real BCTX financials.
  • Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effects of your inputs on BriaCell's valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as clinical trial outcomes, market penetration rates, and operational costs.
  • Instant Valuation Analysis: Quickly computes intrinsic value, NPV, and other financial metrics.
  • High-Precision Accuracy: Leverages BriaCell's real-world data for credible valuation results.
  • Effortless Scenario Simulation: Evaluate various hypotheses and analyze results with ease.
  • Efficiency Booster: Avoid the hassle of creating intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered BriaCell Therapeutics Corp. (BCTX) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for BriaCell Therapeutics Corp.'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • User-Friendly Interface: Perfect for both novice and experienced users.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Feedback: Observe immediate updates to BriaCell Therapeutics Corp.'s (BCTX) valuation as you change inputs.
  • Preloaded Data: Comes with BriaCell’s actual financial information for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Accurately assess BriaCell Therapeutics Corp.'s (BCTX) fair value prior to making investment choices.
  • CFOs: Utilize a high-quality DCF model for financial reporting and analysis specific to BriaCell Therapeutics Corp. (BCTX).
  • Consultants: Efficiently modify the template for valuation reports tailored to BriaCell Therapeutics Corp. (BCTX) clients.
  • Entrepreneurs: Acquire knowledge about financial modeling practices employed by leading biotech firms like BriaCell Therapeutics Corp. (BCTX).
  • Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to the biotech sector.

What the Template Contains

  • Preloaded BCTX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.